Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil and Olfactory Deficits in MCI and AD
NCT01951118Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Oct 2013
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of donepezil in Alzheimer's disease (AD), Mild Cognitive Impairment (MCI), sponsored by New York State Psychiatric Institute. Started Oct 2013; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT01951118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01951118.